Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations

Current Opinion in Neurology

Volumn 14, Issue 2, 2001, Pages 171-176

  Shahbazian, Mona D ^a   Zoghbi, Huda Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; UNCLASSIFIED DRUG;

CPG ISLAND; DISEASE SEVERITY; GENE CONTROL; GENE MUTATION; GENOTYPE; HUMAN; LEARNING DISORDER; MENTAL DEFICIENCY; MOLECULAR GENETICS; PHENOTYPE; RETT SYNDROME; REVIEW; TRANSCRIPTION REGULATION; X CHROMOSOME INACTIVATION;

BRAIN; CHILD, PRESCHOOL; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FEMALE; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MUTATION; PHENOTYPE; REPRESSOR PROTEINS; RETT SYNDROME; X CHROMOSOME;

EID: 0035072804     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200104000-00006     Document Type: Review

References (49)

1. Rett's syndrome: Prevalence and impact on progressive severe mental retardation in girls
2. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases
3. Diagnostic criteria for Rett syndrome
4. Rett syndrome: Exclusion mapping following the hypothesis of germinal mosaicism for new X-linked mutations
5. Examination of X chromosome markers in Rett syndrome: Exclusion mapping with a novel variation on multilocus linkage analysis
6. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map
7. A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map
8. Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28
9. Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28
10. Chromosome mapping of Rett syndrome: A likely candidate region on the telomere of Xq
11. Rett syndrome is caused by mutations in X linked MECP2, encoding methyl-CpG-binding protein 2
12. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA
13. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2
14. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
15. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
16. MeCP2 driven transcriptional repression in vitro: Selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery
17. A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression
18. Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots
19. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome
20. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
21. MECP2 mutations account for most cases of typical forms of Rett syndrome
22. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location
23. Mutations in the MECP2 gene in a cohort of girls with Rett syndrome
24. Rett syndrome: Analysis of MECP2 and clinical characterization of 31 patients
25. Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome
26. Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome
27. Mutation screening in Rett syndrome patients
28. A splicing-dependent regulatory mechanism that detects translation signals
29. Effects of Rett syndrome mutations of the methyl CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA
30. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA
31. Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2
32. Clinical delineation of Rett syndrome variants
33. Preserved speech variant is allelic of classic Rett syndrome
34. Two affected boys in a Rett syndrome family: Clinical and molecular findings
35. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males
36. MECP2 mutation in male patients with non-specific X linked mental retardation
37. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males
38. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
39. Rett syndrome: A surprising result of mutation in MECP2
40. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
41. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene
42. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
43. Tissue-specific transcriptional regulation of human leukosialin (CD43) gene is achieved by DNA methylation
44. Identification and characterization of a family of mammalian methyl-CpG binding proteins
45. Active repression of methylated genes by the chromosomal protein MBD1
46. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
47. Stac, a novel neuron-specific protein with cysteine-rich and SH3 domains
48. GFAP gene methylation in different neural cell types from rat brain
49. The DNA methyltransferase inhibitor 5-azacytidine specifically alters the expression of helix-loop-helix proteins Id1, Id2 and Id3 during neuronal differentiation